Hepatic Metastases Terminated Phase 2 Trials for Everolimus (DB01590)

Also known as: Metastases to liver / Liver Metastases / Metastatic neoplasm of liver / Cancer of liver, secondary / Metastasis to liver / Malignant neoplasm of liver, specified as secondary

IndicationStatusPhase
DBCOND0032606 (Hepatic Metastases)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02031536Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With SurgeryTreatment